H.B. Fuller (FUL) 주식 개요
HB 풀러 컴퍼니는 자회사와 함께 접착제, 실란트, 코팅제, 폴리머, 테이프, 캡슐화제, 첨가제 및 기타 특수 화학 제품을 공식화, 제조 및 판매합니다. 자세히 보기
FUL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
H.B. Fuller Company 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | US$64.86 |
| 52주 최고가 | US$68.63 |
| 52주 최저가 | US$48.71 |
| 베타 | 0.96 |
| 1개월 변동 | 13.97% |
| 3개월 변동 | 31.59% |
| 1년 변동 | 19.89% |
| 3년 변동 | 1.06% |
| 5년 변동 | 1.66% |
| IPO 이후 변동 | 2,572.34% |
최근 뉴스 및 업데이트
분석 기사 • Jun 18
H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report
H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...Seeking Alpha • Jun 16
H.B. Fuller: Margin Growth Looks Unsustainable
Summary H.B. Fuller is rated a sell due to persistent revenue declines, cost inflation, and acquisition risks despite margin improvements. FUL's topline continues to shrink as price hikes fail to offset volume declines; margin gains are driven by transient cost synergies and divestitures. The proposed $800M AMS acquisition risks over-leveraging FUL’s balance sheet, drawing activist pushback and raising medium-term risk. FUL trades at a sales multiple of 1, below the sector median, reflecting weak growth and uncertain outlook if topline recovery fails. Read the full article on Seeking Alpha
내러티브 업데이트 • Jun 16
FUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook
Analysts have made a small, valuation-driven adjustment to their view on H.B. Fuller, with the blended price target holding close to prior levels as updated models reflect a slightly lower discount rate, largely stable fair value at about $70, and balanced input from recent upgrades and price target revisions across the Street. Analyst Commentary Recent commentary on H.B. Fuller centers on how potential corporate actions and updated models could influence the stock’s risk and reward profile, with JPMorgan’s upgrade and various price target changes framing a mixed but valuation conscious view.Recent updates
분석 기사 • Jun 18
H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report
H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...Seeking Alpha • Jun 16
H.B. Fuller: Margin Growth Looks Unsustainable
Summary H.B. Fuller is rated a sell due to persistent revenue declines, cost inflation, and acquisition risks despite margin improvements. FUL's topline continues to shrink as price hikes fail to offset volume declines; margin gains are driven by transient cost synergies and divestitures. The proposed $800M AMS acquisition risks over-leveraging FUL’s balance sheet, drawing activist pushback and raising medium-term risk. FUL trades at a sales multiple of 1, below the sector median, reflecting weak growth and uncertain outlook if topline recovery fails. Read the full article on Seeking Alpha내러티브 업데이트 • Jun 16
FUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook
Analysts have made a small, valuation-driven adjustment to their view on H.B. Fuller, with the blended price target holding close to prior levels as updated models reflect a slightly lower discount rate, largely stable fair value at about $70, and balanced input from recent upgrades and price target revisions across the Street. Analyst Commentary Recent commentary on H.B. Fuller centers on how potential corporate actions and updated models could influence the stock’s risk and reward profile, with JPMorgan’s upgrade and various price target changes framing a mixed but valuation conscious view.내러티브 업데이트 • Jun 02
FUL: Proposed Medical Solutions Deal Will Shape Long Term Outlook
Analysts kept their fair value estimate for H.B. Fuller steady at $70.43 while adjusting assumptions such as the discount rate and long-term growth. This reflected mixed recent price target moves as firms reassessed the stock around potential corporate actions and valuation.내러티브 업데이트 • Apr 26
FUL: Raised Guidance And P/E Assumptions Will Support Stronger Long Term Outlook
Analysts have adjusted their outlook on H.B. Fuller, with offsetting moves such as a $3 increase in the price target at Citi and a $3 reduction at UBS. These changes are framed around updated views on valuation inputs such as the discount rate and the assumed future P/E multiple.내러티브 업데이트 • Apr 12
FUL: Long Term Assumptions Will Support Balanced Outlook Despite Mixed Guidance
The analyst price target for H.B. Fuller edges slightly lower to about $70.43 from roughly $70.71, as analysts balance recent target increases from several firms with more cautious revisions tied to adjusted growth, margin, and P/E assumptions. Analyst Commentary Recent Street research on H.B. Fuller presents a mixed picture, with several firms adjusting price targets both higher and lower over the past few months.내러티브 업데이트 • Mar 29
FUL: Higher Long Term Assumptions Will Support Upside Despite Mixed Guidance
Analysts trimmed the average H.B. Fuller price target by about $1 to $70.71, reflecting a mix of recent upward and downward revisions as they reassessed assumptions on growth, profitability, and valuation multiples. Analyst Commentary Recent research on H.B. Fuller features a mix of higher and lower price targets.내러티브 업데이트 • Mar 14
FUL: Higher P/E Assumptions Will Support Upside Despite Muted Revenue Outlook
Analysts have lifted their consolidated price target on H.B. Fuller by several dollars, with recent $2 to $6 upward revisions tied to their updated views on the company’s earnings power and P/E assumptions. Analyst Commentary Bullish analysts raising their targets by $2 to $6 are largely reacting to updated assumptions on H.B. Fuller’s earnings power and the P/E they are willing to apply to those earnings.내러티브 업데이트 • Feb 28
FUL: Free Cash Flow Support Will Offset Modest Outlook And Future P/E Assumptions
H.B. Fuller’s analyst price target has been lifted by several firms, with recent increases of $2 to $6 reflecting analysts’ updated views on its earnings profile and modest adjustments to assumptions such as discount rate, long-term revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research points to a cluster of higher price targets for H.B. Fuller, with adjustments in the range of $2 to $6.내러티브 업데이트 • Feb 14
FUL: Free Cash Flow Support Will Balance Organic Headwinds And Future P/E Expectations
The Street has nudged its view on H.B. Fuller higher, with analysts lifting price targets by $2 to $6 as they point to a mix of free cash flow support and valuation considerations, even as they flag near term organic growth headwinds. Analyst Commentary Recent Street research clusters around a common theme for H.B. Fuller, with price target increases framed against ongoing pressure on near term organic growth.내러티브 업데이트 • Jan 31
FUL: Free Cash Flow Support Will Underpin Higher Future P/E Expectations
Analysts have lifted their price targets on H.B. Fuller by between $2 and $6, citing updated views on valuation, free cash flow support, and a slightly higher assumed future P/E multiple in their models. Analyst Commentary Recent research updates show a cluster of higher price targets for H.B. Fuller, with several firms revisiting their models to reflect revised valuation assumptions, free cash flow support, and modestly higher assumed future P/E multiples.내러티브 업데이트 • Jan 17
FUL: Higher P/E Expectations Will Shape Medium Term Earnings Power
Analysts have raised their price targets for H.B. Fuller, reflected in the fair value estimate increasing from $68.83 to $71.71. This change is based on a higher assumed future P/E multiple, along with slightly revised assumptions for the discount rate, revenue growth, and profit margins.분석 기사 • Jan 08
Investors Will Want H.B. Fuller's (NYSE:FUL) Growth In ROCE To Persist
What are the early trends we should look for to identify a stock that could multiply in value over the long term...분석 기사 • Nov 14
We Think H.B. Fuller (NYSE:FUL) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Oct 03
There May Be Reason For Hope In H.B. Fuller's (NYSE:FUL) Disappointing Earnings
Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...분석 기사 • Sep 30
H.B. Fuller Company Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Shareholders might have noticed that H.B. Fuller Company ( NYSE:FUL ) filed its quarterly result this time last week...내러티브 업데이트 • Sep 28
ND Industries Integration And HHC Pricing Will Secure Stability
Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment. Analyst Commentary Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.분석 기사 • Aug 30
Estimating The Intrinsic Value Of H.B. Fuller Company (NYSE:FUL)
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$53.78 With US$61.05...분석 기사 • Aug 14
H.B. Fuller Company's (NYSE:FUL) P/E Is On The Mark
H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...분석 기사 • Jul 30
Is Now The Time To Look At Buying H.B. Fuller Company (NYSE:FUL)?
While H.B. Fuller Company ( NYSE:FUL ) might not have the largest market cap around , it saw a double-digit share price...분석 기사 • Jul 15
There's Been No Shortage Of Growth Recently For H.B. Fuller's (NYSE:FUL) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...분석 기사 • May 22
Is H.B. Fuller Company (NYSE:FUL) Worth US$54.7 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$41.64 H.B. Fuller is...분석 기사 • May 07
H.B. Fuller (NYSE:FUL) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...분석 기사 • Apr 19
H.B. Fuller (NYSE:FUL) Will Pay A Larger Dividend Than Last Year At $0.235
The board of H.B. Fuller Company ( NYSE:FUL ) has announced that it will be increasing its dividend by 5.6% on the 13th...분석 기사 • Apr 10
Here's What To Make Of H.B. Fuller's (NYSE:FUL) Decelerating Rates Of Return
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...분석 기사 • Mar 13
Shareholders Should Be Pleased With H.B. Fuller Company's (NYSE:FUL) Price
With a price-to-earnings (or "P/E") ratio of 22.4x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...분석 기사 • Feb 21
What Is H.B. Fuller Company's (NYSE:FUL) Share Price Doing?
H.B. Fuller Company ( NYSE:FUL ), is not the largest company out there, but it saw significant share price movement...분석 기사 • Jan 23
We Think You Can Look Beyond H.B. Fuller's (NYSE:FUL) Lackluster Earnings
Shareholders appeared unconcerned with H.B. Fuller Company's ( NYSE:FUL ) lackluster earnings report last week. We...Seeking Alpha • Jan 17
Evaluation Of H.B. Fuller After A 30% Decline
Summary H.B. Fuller missed analysts' estimates for the second consecutive quarter, leading to a 3% stock decline and hitting a nearly 3-year low. Despite recent stagnation, H.B. Fuller expects to realize price hikes in 2025, with projected earnings per share growth of 5% and potential for significant future gains. The stock's sharp 30% decline is attributed to its initially high valuation; it now trades at a more reasonable 15.0x forward P/E ratio. Given its cyclical nature, H.B. Fuller offers substantial upside potential but is not a long-term hold; investors should reassess at $79 target. Read the full article on Seeking Alpha분석 기사 • Dec 21
Does H.B. Fuller (NYSE:FUL) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Seeking Alpha • Dec 08
H.B. Fuller: Still Not Fully Onboard
Summary H.B. Fuller faces lackluster revenue growth and margin pressure despite M&A activities, leading to cautious investment sentiment and a neutral stance. The company has a long heritage, generating $3.5 billion in 2023 sales, but inventory de-stocking and soft trends have weighed on sales growth for a while. Recent acquisitions and reorganization efforts have increased net debt to $2 billion, raising leverage ratios to 3.2-3.3 times amidst flat organic sales. I remain cautious and seek an entry point in the mid-sixties, given the current 18 times earnings multiple and expensive portfolio reshuffling. Read the full article on Seeking Alpha분석 기사 • Dec 07
Earnings Not Telling The Story For H.B. Fuller Company (NYSE:FUL)
With a price-to-earnings (or "P/E") ratio of 22.6x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...주주 수익률
| FUL | US Chemicals | US 시장 | |
|---|---|---|---|
| 7D | 2.0% | 0.08% | 1.7% |
| 1Y | 19.9% | 8.3% | 25.1% |
수익률 대 산업: FUL은 지난 1년 동안 8.3%의 수익을 기록한 US Chemicals 산업보다 더 좋은 성과를 냈습니다.
수익률 대 시장: FUL은 지난 1년 동안 25.1%를 기록한 US 시장보다 저조한 성과를 냈습니다.
주가 변동성
| FUL volatility | |
|---|---|
| FUL Average Weekly Movement | 5.9% |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
안정적인 주가: FUL는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: FUL의 주간 변동성(6%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 1887 | 7,100 | Celeste Mastin | www.hbfuller.com |
HB 풀러 컴퍼니는 자회사와 함께 접착제, 실란트, 코팅제, 폴리머, 테이프, 캡슐화제, 첨가제 및 기타 특수 화학 제품을 공식화, 제조 및 판매합니다. 이 회사는 세 가지 부문으로 운영됩니다: 위생, 건강 및 소모성 접착제, 엔지니어링 접착제, 건축용 접착제 솔루션입니다. 위생, 건강 및 소모품 접착제 부문은 포장, 변환, 부직포 및 위생, 의료 및 미용 등 다양한 시장의 응용 분야를 위한 열가소성, 열경화성, 반응성, 수성 및 솔벤트 기반 제품과 같은 특수 산업용 접착제를 생산 및 공급합니다.
H.B. Fuller Company 기초 지표 요약
| FUL 기초 통계 | |
|---|---|
| 시가총액 | US$3.53b |
| 순이익 (TTM) | US$159.76m |
| 매출 (TTM) | US$3.46b |
22.1x
주가수익비율(P/E)1.0x
주가매출비율(P/S)FUL는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| FUL 손익계산서 (TTM) | |
|---|---|
| 매출 | US$3.46b |
| 매출원가 | US$2.35b |
| 총이익 | US$1.10b |
| 기타 비용 | US$941.96m |
| 순이익 | US$159.76m |
최근 보고된 실적
Feb 28, 2026
다음 실적 발표일
Jun 24, 2026
| 주당순이익(EPS) | 2.93 |
| 총이익률 | 31.88% |
| 순이익률 | 4.62% |
| 부채/자본 비율 | 107.9% |
FUL의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기배당
1.4%
현재 배당 수익률32%
배당 성향기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/06/18 13:32 |
| 종가 | 2026/06/18 00:00 |
| 수익 | 2026/02/28 |
| 연간 수익 | 2025/11/29 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
H.B. Fuller Company는 12명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Ghansham Panjabi | Baird |
| Paretosh Misra | Berenberg |
| Patrick Cunningham | Citigroup Inc |